Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

Detalles Bibliográficos
Autores principales: Ghobadi, Armin, Landmann, Jack H., Carter, Alun, Cooper, Matthew L., Selli, Mehmet Emrah, Chang, Jufang, Baker, Matthew, Miller, Christopher A., Ferraro, Francesca, Chen, David Y., Smith, Amanda M., LaValle, Taylor A., Duncavage, Eric J., Chou, Justin, Tam, Victor, Benoun, Joseph M., Nater, Jenny, Scholler, Nathalie, Milletti, Francesca, Vezan, Remus, Bot, Adrian, Rossi, John M., Singh, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582720/
https://www.ncbi.nlm.nih.gov/pubmed/35858291
http://dx.doi.org/10.1182/bloodadvances.2022007705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582720/
https://www.ncbi.nlm.nih.gov/pubmed/35858291
http://dx.doi.org/10.1182/bloodadvances.2022007705

Ejemplares similares